➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

ETHOSUXIMIDE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for ethosuximide and what is the scope of patent protection?

Ethosuximide is the generic ingredient in two branded drugs marketed by Akorn, Bionpharma Inc, Heritage Pharms Inc, Puracap Pharm Llc, Strides Pharma, Parke Davis, Mikart, Pharm Assoc, Teva Pharms, and Parke-davis, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for ethosuximide. Eleven suppliers are listed for this compound.

Drug Prices for ETHOSUXIMIDE

See drug prices for ETHOSUXIMIDE

Recent Clinical Trials for ETHOSUXIMIDE

Identify potential brand extensions & 505(b)(2) entrants

Johns Hopkins UniversityPhase 3
Tanta UniversityPhase 3
Zhejiang UniversityEarly Phase 1

See all ETHOSUXIMIDE clinical trials

Pharmacology for ETHOSUXIMIDE
Medical Subject Heading (MeSH) Categories for ETHOSUXIMIDE

US Patents and Regulatory Information for ETHOSUXIMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma ETHOSUXIMIDE ethosuximide CAPSULE;ORAL 211928-001 Feb 19, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Mikart ETHOSUXIMIDE ethosuximide SYRUP;ORAL 040506-001 Dec 22, 2003 AA RX No No   Start Trial   Start Trial   Start Trial
Parke-davis ZARONTIN ethosuximide SYRUP;ORAL 080258-001 Approved Prior to Jan 1, 1982 AA RX No Yes   Start Trial   Start Trial   Start Trial
Bionpharma Inc ETHOSUXIMIDE ethosuximide CAPSULE;ORAL 040430-001 Oct 28, 2002 AB RX No No   Start Trial   Start Trial   Start Trial
Heritage Pharms Inc ETHOSUXIMIDE ethosuximide CAPSULE;ORAL 200892-001 Sep 25, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.